Boston Private Wealth Llc reports 3.90% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Boston Private Wealth Llc
Latest Disclosed Ownership	59,578 shares
Latest Disclosed Value	$ 3,613,398

On April 17, 2026 - Boston Private Wealth Llc filed a 13F-HR form disclosing ownership of 59,578 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $3,123,079 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 61,995 shares of Bristol-Myers Squibb Company. This represents a change in shares of -3.90% during the quarter. The current value of the position is $2,825,785 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-17	2026-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	59,578	-2,417	-3.90	3,613	8.04	0.2380
2026-02-04	2025-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	61,995	-9,404	-13.17	3,344	3.85	0.1972
2025-11-06	2025-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	71,399	5,038	7.59	3,220	4.85	0.1733
2025-08-14	2025-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	66,361	66,361		3,072		0.1646
2025-05-14	2025-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	0	-87,294	-100.00	0	-100.00
2025-02-05	2024-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	87,294	87,294		4,937		0.0922
2024-10-18	2024-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	0	-86,707	-100.00	0	-100.00
2024-08-06	2024-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	86,707	-7,272	-7.74	3,601	-29.36	0.0891
2024-05-15	2024-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	93,979	536	0.57	5,096	6.30	0.1136
2024-01-30	2023-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	93,443	367	0.39	4,795	-11.26	0.1166
2023-10-23	2023-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	93,076	-11,731	-11.19	5,402	-19.40	0.1186
2023-07-24	2023-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	104,807	-9,827	-8.57	6,702	-15.65	0.1211
2023-05-12	2023-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	114,634	-8,773	-7.11	7,945	-10.52	0.1110
2023-02-10	2022-12-31	13F	Bristol-Myers Squibb	COM	110122108	123,407	-14,410	-10.46	8,879	-9.37	0.1199
2022-11-09	2022-09-30	13F	Bristol-Myers Squibb	COM	110122108	137,817	12,760	10.20	9,797	1.73	0.1431
2022-08-16	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	125,057	1,191	0.96	9,630	6.47	0.1481
2022-05-13	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	123,866	-1,087	-0.87	9,045	16.10	0.1211
2022-02-15	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	124,953	-2,719	-2.13	7,791	3.12	0.1278
2021-11-09	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	127,672	-2,951	-2.26	7,555	-13.45	0.0971
2021-08-13	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	130,623	-2,245	-1.69	8,729	4.07	0.1107
2021-05-11	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	132,868	1,491	1.13	8,388	2.92	0.1168
2021-02-10	2020-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	131,377	-8,677	-6.20	8,150	-3.48	0.1196
2020-11-10	2020-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	140,054	-1,492	-1.05	8,444	1.45	0.1393
2020-08-05	2020-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	141,546	-2,505	-1.74	8,323	3.66	0.1547
2020-05-11	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	144,051	-8,705	-5.70	8,029	-18.11	0.1949
2020-02-13	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	152,756	52,233	51.96	9,805	92.37	0.1785
2019-11-01	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	100,523	-4,858	-4.61	5,097	6.65	0.1015
2019-07-10	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	105,381	-936	-0.88	4,779	-5.78	0.1605
2019-05-14	2019-03-31	13F	Bristol-Myers Squibb	COM	110122108	106,317	-37,065	-25.85	5,072	-31.95	0.2003
2019-02-14	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	143,382	-2,352	-1.61	7,453	-17.62	0.3180
2018-11-13	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	145,734	-4,922	-3.27	9,047	8.52	0.3200
2018-08-14	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	150,656	-3,080	-2.00	8,337	-14.26	0.3197
2018-05-11	2018-03-31	13F	Bristol-Myers Squibb	COM	110122108	153,736	-9,858	-6.03	9,724	-3.00	0.3730
2018-02-13	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	163,594	-4,164	-2.48	10,025	-6.25	0.3771
2017-11-13	2017-09-30	13F	Bristol-Myers Squibb	COM	110122108	167,758	-1,948	-1.15	10,693	13.08	0.4112
2017-08-04	2017-06-30	13F	Bristol-Myers Squibb	COM	110122108	169,706	-12,734	-6.98	9,456	-4.69	0.3710
2017-05-11	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	182,440	-45,735	-20.04	9,921	-25.60	0.3952
2017-02-15	2016-12-31	13F	Bristol-Myers Squibb	COM	110122108	228,175	-45,121	-16.51	13,335	-9.51	0.5517
2016-11-15	2016-09-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	273,296	24,208	9.72	14,736	-19.56	0.5993
2016-11-14	2016-09-30	13F	Bristol-Myers Squibb	COM	110122108	249,088	0		18,320		0.7474
2016-08-01	2016-06-30	13F	Bristol-Myers Squibb	COM	110122108	249,088	-32,869	-11.66	18,320	1.72	0.7474
2016-05-13	2016-03-31	13F	Bristol-Myers Squibb	COM	110122108	281,957	13,407	4.99	18,011	-2.51	0.7333
2016-02-12	2015-12-31	13F	Bristol-Myers Squibb	COM	110122108	268,550	-17,448	-6.10	18,474	9.11	0.7287
2015-11-12	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	285,998	-8,166	-2.78	16,931	-13.50	0.6563
2015-08-13	2015-06-30	13F	Bristol-Myers Squibb	COM	110122108	294,164	-14,092	-4.57	19,574	-0.98	0.6478
2015-05-12	2015-03-31	13F	Bristol-Myers Squibb	COM	110122108	308,256	-2,700	-0.87	19,768	7.69	0.6382
2015-02-10	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	310,956	310,956		18,356		0.5936

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.